International safety notice

Reactivo cobas® SARS-CoV-2 & Influenza A/B Test (referencia: 09211101190; identificador: 00875197006360) para uso en cobas® Liat® System (referencia: 07341920190; identificador: 07613336100097).

Spain / AEMPS · ESP · Mar 26, 2021

Key facts

Title Reactivo cobas® SARS-CoV-2 & Influenza A/B Test (referencia: 09211101190; identificador: 00875197006360) para uso en cobas® Liat® System (referencia: 07341920190; identificador: 07613336100097).
Regulator Spain / AEMPS
Country ESP
Brand Reactivo cobas® SARS-CoV-2 & Influenza A/B Test (referencia: 09211101190; identificador: 00875197006360) para uso en cobas® Liat® System (referencia: 07341920190; identificador: 07613336100097).
Manufacturer Roche Molecular Systems, Estados Unidos.
Models 2021PUEDE, 2021-168, 00875197006360, 09211101190, SARS-COV-2, COVID-19, 07341920190, 91.822.52.89, 171-173, V3.3.0, 28022, MAR-2021 and 12 more
Event type Safety Notice
Date Mar 26, 2021

At a glance

  • No Recall
  • Yes Field safety notice

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About International device safety notices

Field safety notices, recalls and safety alerts published by about 30 national medical device regulators outside the United States, matched by Orca1 to FDA device data.

Source: National medical device regulators (as listed), compiled by Orca1

Browse all International device safety notices